Aktiesnakken — November 2010
-
-
se den ER interessant
-
nu skal Exiqon bare leverer det 3. kvartal, så er jeg at tælle blandt aktionærerne
-
de har 6x omsætning af bioporto og en mindre markedsværdi og de har vel 100x patenter
-
den har lagt der hele dagen, der kom bare 5k oveni
-
klart. Men hvem styrer den....det er ihvertfald IKKE de professionelle
-
eller??
-microRNA-Array-produktlinje-valgt-som-foretrukken-platform-af-multinationalt-firma.-Slaar-konkurrende-produkt-paa-afgoerende-parametre,-viser-data-praesenteret-paa-europaeisk-miRNA-konferen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind